Trial Profile

A Phase 4 Randomized Trial Comparing Varithena to Endothermal Ablation for the Treatment of the Great Saphenous Vein

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Polidocanol (Primary)
Indications Varicose veins
Focus Therapeutic Use
Acronyms VERITAS
Sponsors Boston Scientific Corporation

Most Recent Events

29 May 2024 Status changed from active, no longer recruiting to discontinued because of the challenges in enrolling patients and difficult insurance coverage landscape.
24 Apr 2024 Planned primary completion date changed from 30 Sep 2024 to 30 Apr 2024.
24 Apr 2024 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com